Practical, topical conversations with experts across the spectrum of ophthalmology. Subscribe for the latest information, evidence-based practice standards, and...
Drs. Davinder Grover and Ronald Fellman join host Dr. Andrew Pouw to discuss their latest innovative surgical advancement: interventional valve-enhancing trabeculotomy (iVEnT), an angle-based minimally invasive glaucoma surgery (MIGS) procedure. Compared with a traditional goniotomy, this alternative approach may be less invasive, sparing tissue and offering faster visual recovery for glaucoma patients. For all episodes or to claim CME credit for selected episodes, visit www.aao.org/podcasts.
-------- Â
51:00
Eye Care for Patients With Intellectual Disability
Dr. Michael Puente joins host Dr. Ben Young to share his experience founding the first eye clinic specifically for adult and pediatric patients with intellectual developmental delay. Dr. Puente provides practical tips for all ophthalmologists to improve their care for this vulnerable population. For all episodes or to claim CME credit for selected episodes, visit www.aao.org/podcasts.
-------- Â
53:26
Dilute Hypochlorous Acid for the Treatment of Periorbital Necrotizing Fasciitis
Drs. Louise Mawn and Jonathan Siktberg sit down with host Dr. Amanda Redfern to share their work on a groundbreaking paradigm shift in the treatment of periorbital necrotizing fasciitis with dilute hypochlorous acid. For all episodes or to claim CME credit for selected episodes, visit www.aao.org/podcasts.
-------- Â
24:38
2025 Retina Update, Part 2: Photobiomodulation, OCT and OCTA Reimbursement, and Surgical Advances
Drs. M. Ali Khan and Ajay Kuriyan join host Dr. Jay Sridhar to discuss updates in the retina space, including the FDA approval of photobiomodulation for dry age-related macular degeneration (AMD), OCT and OCTA reimbursement changes, and surgical technology advances. For all episodes or to claim CME credit for selected episodes, visit www.aao.org/podcasts.
-------- Â
27:43
2025 Retina Update, Part 1: Injectables in the Medical Retina Space
Drs. Ashkan Abbey and Ehsan Rahimy join host Dr. Jay Sridhar to discuss recent developments in the medical retina and injectable space, including faricimab versus high-dose aflibercept, biosimilars for ranibizumab and aflibercept, off-label bevacaziumb shortages, dry age-related macular degeneration (AMD) therapies, private equity acquisitions, and the new drug pipeline. For all episodes or to claim CME credit for selected episodes, visit www.aao.org/podcasts.
Practical, topical conversations with experts across the spectrum of ophthalmology. Subscribe for the latest information, evidence-based practice standards, and innovations in eye care, from the American Academy of Ophthalmology.
South Africa